-
Axis Bank & Security Intelligence Services (SIS) were back in black in Q4FY21 and market experts are upbeat on the stocks
-
Improvement in volumes & operational efficiencies help Tata Steel decrease net debt by Rs.29,390 crores to Rs.75,389 crores
-
Timely intervention by RBI has provided relief to market participants amid the prevailing uncertainty
-
Announcements by RBI pumped up investor sentiment and fresh buying was seen in pharma and bank stocks. The Nifty Pharma index climbed over 4.12% whereas the Nifty Bank jumped 1.59%.
-
Other components of the index also ended the day in green. Meanwhile, Lupin, Aurobindo Pharma, Sun Pharma and Cadila Healthcare also scaled their respective 52-week highs during the day
-
Investors should seize the opportunity to accumulate quality stocks, say analysts
-
Hikal hit an upper circuit of 10% at Rs 313.65 after the company said it signed a 10-year multi-product deal with a leading global pharmaceutical innovator company.
-
Its March-quarter consolidated revenue from operations rose almost 24% to Rs 3,608 crore as against Rs 2,921 crore a year ago
-
A liquidity window of Rs 50,000 crore with tenure of up to 3 years at repo rate being opened till March 31st, 2022. Under the scheme, banks can support entities including vaccine manufacturers, medical facilities, hospitals, and also patients.
-
28 out of 30 Sensex traded in the green. ONGC, Axis Bank, NTPC, Bharti Airtel & IndusInd Bank were trading with gains of up to 3%.